Systematic Triangulation of Pathobiont-Host-Interactions
Rising incidences of chronic disorders and cancer have been linked to reduced microbial diversity. Genetic risk factors are similarly involved in the development of chronic disorders and cancer. The effect of both microbial and ge...
Rising incidences of chronic disorders and cancer have been linked to reduced microbial diversity. Genetic risk factors are similarly involved in the development of chronic disorders and cancer. The effect of both microbial and genetic factors is particularly evident in inflammatory bowel disease (IBD) and colorectal cancer (CRC). However, the identification of specific bacteria that trigger/drive disease or modulate therapy efficacy in IBD and CRC lacks a comprehensive approach. Even less is known about how these bacteria mechanistically induce such effects. The paucity of so far identified disease relevant bacteria and their mode of action, likely lies in the complexity of both the microbiome and the host’s genetic risk factors. We hypothesize that specific bacteria, which do not harm the host under steady state conditions, hijack host pathways in the presence of certain genetic risk factors to drive inflammation, onset and progression of IBD and CRC. We speculate that these bacteria, termed pathobionts, have so far been overlooked due to a lack of methods to triangulate these disease relevant bacteria in multi-factorial disorders like IBD and CRC.
It is our objective to identify these pathobionts and match them to host genetic risk. To do so, we have developed an antibody coating based approach, to identify and culture pathobionts. Now, we want to overhaul our approach to develop a high throughput-pathobiont identification technology. Through machine learning, we then aim to find pathobiont-host genetic risk matches that drive disease and validate these matches in vivo. Lastly, we plan to demonstrate the potential of our new technology and gained knowledge. Through leveraging the gained knowledge, we aim to identify pathobiont-host risk matches in publicly available databases. This will unmask individuals at risk for the development of IBD, CRC and potentially other disorders. This may pave the way for future microbiome-based precision medicine approaches.ver más
Seleccionando "Aceptar todas las cookies" acepta el uso de cookies para ayudarnos a brindarle una mejor experiencia de usuario y para analizar el uso del sitio web. Al hacer clic en "Ajustar tus preferencias" puede elegir qué cookies permitir. Solo las cookies esenciales son necesarias para el correcto funcionamiento de nuestro sitio web y no se pueden rechazar.
Cookie settings
Nuestro sitio web almacena cuatro tipos de cookies. En cualquier momento puede elegir qué cookies acepta y cuáles rechaza. Puede obtener más información sobre qué son las cookies y qué tipos de cookies almacenamos en nuestra Política de cookies.
Son necesarias por razones técnicas. Sin ellas, este sitio web podría no funcionar correctamente.
Son necesarias para una funcionalidad específica en el sitio web. Sin ellos, algunas características pueden estar deshabilitadas.
Nos permite analizar el uso del sitio web y mejorar la experiencia del visitante.
Nos permite personalizar su experiencia y enviarle contenido y ofertas relevantes, en este sitio web y en otros sitios web.